PCM
INSM icon

Prelude Capital Management’s Insmed INSM Stock Holding History

Prelude Capital Management’s Portfolio INSM Stock Details INSM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q4 		– Sell
-90,200
Closed -$1.82M – 1962
2018
Q3 		$1.82M Buy
+90,200
New +$2.04M 0.11% 213
2017
Q4 		– Sell
-500
Closed -$16K – 1510
2017
Q3 		$16K Buy
+500
New +$9.52K ﹤0.01% 1357

Other funds holding INSM

JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
DGM
Darwin Global Management St. Helier, Jersey $3.77B AUM 307.72% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Prelude Capital Management's INSM Position: Q1 2026 in Review

Prelude Capital Management increased its Insmed (INSM) stake by 384% in Q1 2026, buying an estimated $826K and bringing the position to 6,775 shares worth $1.11M. The position accounts for 0.08% of the portfolio, ranked #286.

Prelude Capital Management first reported a position in INSM in Q1 2014 and has held it in 18 quarters since. The position peaked at $3.54M in Q3 2018. 669 funds tracked by Wall St. Rank hold INSM as of Q1 2026.

  • Prelude Capital Management held 6,775 shares of Insmed worth $1.11M as of Q1 2026.
  • Prelude Capital Management bought 5,374 Insmed shares in Q1 2026, an estimated $826K.
  • Insmed made up 0.08% of Prelude Capital Management's portfolio in Q1 2026, its #286 holding.
  • Prelude Capital Management first reported a position in Insmed in Q1 2014 and has held it in 18 quarters since.
  • Prelude Capital Management's Insmed position peaked at $3.54M in Q3 2018.
  • 669 funds tracked by Wall St. Rank held Insmed as of Q1 2026.

Based on Prelude Capital Management's 13F filing for Q1 2026, filed 15 May 2026.